4D Molecular Therapeutics, Inc. (FDMT)

SEC filing

4D Molecular Therapeutics, Inc.

FDMT · CIK 1650648

4 · Sep 3, 2026 · Chief Legal Officer Bizily Scott sold 584 shares at $14.00/share ($8,176); exercised options for 1,168 shares

Chief Legal Officer Bizily Scott sold 584 shares at $14.00/share ($8,176); exercised options for 1,168 shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).